Novavax originally showed its vaccine was safe and effective in a 30,000-person clinical trial. The FDA had been on track to ...

Novavax shares surged more than 17% before the bell on Monday, following the long-delayed approval of its COVID-19 vaccine ...

Jordan Hill allegedly claimed to have businesses with monthly payrolls ranging from $4,000 to $210,000, using fake documents ...

A new wave of COVID-19 cases, driven by the JN.1 Omicron sub-variant, is emerging in parts of Asia, raising global concerns.

At present, government data shows 257 active COVID-19 cases across various states in the country, with most of them coming ...

The JN.1 variant is a newer version of the coronavirus that comes from the Omicron BA.2.86 family. It was first found in ...

The vaccine, Nuvaxovid, is the third coronavirus shot to gain full approval, joining vaccines from Pfizer and Moderna. It has ...

Since the COVID-19 pandemic, there has been a decline in U.S. vaccine uptake, while widespread misinformation and distrust ...

The Ministry of Health and Family Welfare reviews the recent COVID-19 surge in Singapore and Hong Kong. India reports 257 ...

What sets JN.1 apart is a unique mutation in the spike protein — the part of the virus that binds to human cells. This ...

Regulators will soon “unleash a massive framework” for how vaccines are tested and approved, according to FDA Commissioner ...

The JN.1 variant is a descendant of the Omicron BA.2.86 lineage. First discovered in August 2023, JN.1 “has acquired the ...